New treatments like dotinurad provide safer, more effective solutions for millions battling gout and hyperuricemia.

XORTX Therapeutics Inc. is a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease. The company is actively involved in creating ...

XORTX to focus on late stage allopurinol intolerant gout program; discussion with FDA planned for first half 2025 regarding ...

You might just know someone, close or distant, who has struggled with drug addiction at one point in time. It could be a distant relative or someone you went to school with, but the sheer probability ...

Substance abuse in the United States is one of the leading health conditions impacting millions of lives and due to many types of drug addictions. Since 2000, there have been 700,000 overdose deaths ...

In 2025, MG will also begin offering new models from its freshly introduced ‘Select’ dealerships that has been conceptualised for its premium range of cars Morris Garages, commonly known as MG ...

Hopefully, the approval will help prevent shortages triggered by demand for injectable weight loss drugs such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) There is still no ...

THURSDAY, Dec. 26, (2024 HealthDay News) -- The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a daily injectable GLP-1 medicine for ...

MG is back in South Africa, with the local arm of the automaker releasing pricing and specifications for its ZS, HS and Cyberster model line-ups. Here’s what you can expect. Looking for your ...

It’s the only ragtop two-seater EV out there, and while some may use that as an excuse to rest on their laurels and phone the job in, MG has put a lot of effort into this one. It’s available ...

Drug discovery is the process through which potential new medicines are identified. It involves a wide range of scientific disciplines, including biology, chemistry and pharmacology. Targeted ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced ...